Search

Displaying results 9851 - 9860 of 10000 in total
  1. Drug

    Denagliptin

    go.drugbank.com/drugs/DB16134
    Investigational

    Denagliptin is under investigation in clinical trial NCT00387972 (Study of Denagliptin in Subjects With Type 2 Diabetes Mellitus (T2DM)).

  2. Drug

    Lapaquistat

    go.drugbank.com/drugs/DB16215
    Investigational

    Lapaquistat is under investigation in clinical trial NCT00256178 (Efficacy of Lapaquistat Acetate and Simvastatin in Subjects With Primary Dyslipidemia.).

  3. Drug

    Nidufexor

    go.drugbank.com/drugs/DB16255
    Investigational

    Nidufexor is under investigation in clinical trial NCT03804879 (Safety, Tolerability and Efficacy of LMB763 in Patients With Diabetic Nephropathy).

  4. Drug

    Pecavaptan

    go.drugbank.com/drugs/DB16279
    Investigational

    Pecavaptan is under investigation in clinical trial NCT03901729 (A Trial to Study BAY1753011 in Patients With Congestive Heart Failure).

  5. Drug

    GSK-2981278

    go.drugbank.com/drugs/DB16319
    Investigational

    GSK-2981278 is under investigation in clinical trial NCT03004846 (A Study of GSK2981278 Ointment in Subjects With Plaque Psoriasis).

    Synonyms: Ror gama modulator 1
  6. Drug

    Zotatifin

    go.drugbank.com/drugs/DB16408
    Investigational

    Zotatifin is under investigation in clinical trial NCT04092673 (Study of Eft226 in Subjects With Selected Advanced Solid Tumor Malignancies).

  7. Drug

    Nofazinlimab

    go.drugbank.com/drugs/DB18852
    Investigational

    Nofazinlimab is under investigation in clinical trial NCT04194775 (A Study of Nofazinlimab (CS1003) in Subjects With Advanced Hepatocellular Carcinoma).

  8. Drug

    Vamikibart

    go.drugbank.com/drugs/DB18896
    Investigational

    Vamikibart is under investigation in clinical trial NCT05642312 (A Study to Investigate Vamikibart in Participants With Uveitic Macular Edema).

  9. Drug

    ORC-13661

    go.drugbank.com/drugs/DB18903
    Investigational

    ORC-13661 is under investigation in clinical trial NCT05730283 (Prevention of Ototoxicity in NTM Patients Treated With IV Amikacin).

  10. Drug

    Narlumosbart

    go.drugbank.com/drugs/DB19002
    Investigational

    Narlumosbart is under investigation in clinical trial NCT06314698 (Narlumosbart Compared With Denosumab in Patients With Multiple Myeloma Bone Disease).